Natera, Inc. (NTRA) stock

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value

$414.30−21.70 (-4.98%)

Close on Oct 30, 2026Market cap $59.72BP/E –Yield –

Earnings

Natera's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Nov 5, 2026

Q3 FY2026 · estimated, after the close

Revenue, Q2 FY2026

$752.80M

+37.7% on a year earlier

EPS, Q2 FY2026

-$0.47

-$0.74 a year earlier

Latest guidance

Raised

Aug 6, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of Natera's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Source
Q3 FY2026ended Sep 30, 2026	Nov 5, 2026Expected	–	–	–	–
Q2 FY2026ended Jun 30, 2026	Aug 6, 2026after the close	$752.80M	+37.7%	-$0.47	Release
Q1 FY2026ended Mar 31, 2026	May 7, 2026after the close	$696.60M	+38.8%	-$0.60	Release
Q4 FY2025ended Dec 31, 2025	Feb 26, 2026after the close	$665.50M	+39.8%	–	Release
Q3 FY2025ended Sep 30, 2025	Nov 6, 2025after the close	$592.20M	+34.7%	-$0.64	Release
Q2 FY2025ended Jun 30, 2025	Aug 7, 2025after the close	$546.60M	+32.2%	-$0.74	Release
Q1 FY2025ended Mar 31, 2025	May 8, 2025after the close	$501.80M	+36.5%	-$0.50	Release
Q4 FY2024ended Dec 31, 2024	Feb 27, 2025after the close	$476.10M	+53.0%	-$0.41	Release
Q3 FY2024ended Sep 30, 2024	Nov 12, 2024after the close	$439.80M	+63.9%	-$0.26	Release
Q2 FY2024ended Jun 30, 2024	Aug 8, 2024after the close	$413.40M	+58.1%	-$0.30	Release
Q1 FY2024ended Mar 31, 2024	May 9, 2024after the close	$367.70M	+52.1%	-$0.56	Release
Q4 FY2023ended Dec 31, 2023	Feb 28, 2024after the close	$311.10M	+43.2%	-$0.65	Release
Q3 FY2023ended Sep 30, 2023	Nov 8, 2023after the close	$268.30M	+27.4%	-$0.95	Release
Q2 FY2023ended Jun 30, 2023	Aug 3, 2023after the close	$261.40M	+31.9%	-$0.97	Release
Q1 FY2023ended Mar 31, 2023	May 9, 2023after the close	$241.80M	+24.6%	-$1.23	Release
Q4 FY2022ended Dec 31, 2022	Feb 28, 2023after the close	$217.30M	+25.6%	-$1.37	Release
Q3 FY2022ended Sep 30, 2022	Nov 8, 2022after the close	$210.60M	+33.2%	-$1.25	Release
Q2 FY2022ended Jun 30, 2022	Aug 4, 2022after the close	$198.20M	–	-$1.50	Release
Q1 FY2022ended Mar 31, 2022	May 5, 2022after the close	$194.10M	–	-$1.45	Release
Q4 FY2021ended Dec 31, 2021	Feb 24, 2022after the close	$173.00M	–	-$1.48	Release
Q3 FY2021ended Sep 30, 2021	Nov 4, 2021after the close	$158.10M	–	-$1.63	Release
Q2 FY2021ended Jun 30, 2021	Jul 20, 2021after the close	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	May 6, 2021after the close	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Feb 25, 2021after the close	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Nov 5, 2020after the close	–	–	–	Filing
Q2 FY2020ended Jun 30, 2020	Aug 5, 2020after the close	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Natera's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
total revenue	FY2026	$2.85B – $2.91B	$2.74B – $2.82B	Raised	Aug 6, 2026
total revenue	FY2026	$2.62B – $2.70B	–	New	Feb 26, 2026
gross marginGAAP	FY2026	64% – 66%	–	New	May 7, 2026
gross margin 1	FY2026	64% – 66%	–	New	Aug 6, 2026
gross margin 1GAAP	FY2026	63% – 65%	–	New	Feb 26, 2026
research and development costs	FY2026	$800.00M – $900.00M	$800.00M – $900.00M	Lowered	Aug 6, 2026
research and development costs	FY2026	$750.00M – $850.00M	–	Lowered	Feb 26, 2026
selling, general and administrative costs	FY2026	$1.13B – $1.23B	$1.13B – $1.23B	Raised	Aug 6, 2026
selling, general and administrative costs	FY2026	$1.13B – $1.23B	–	New	Feb 26, 2026

Guidance vs results

The last range Natera gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	Revenue	$2.18B – $2.26B	$2.31BΣ4Q	Above range

Guidance history

Every forecast Natera put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Aug 6, 2026	gross margin 1	FY2026	64% – 66%	New
Aug 6, 2026	selling, general and administrative costs	FY2026	$1.13B – $1.23B	Raised
Aug 6, 2026	research and development costs	FY2026	$800.00M – $900.00M	Lowered
Aug 6, 2026	total revenue	FY2026	$2.85B – $2.91B	Raised
May 7, 2026	gross margin	FY2026	64% – 66%	New
May 7, 2026	selling, general and administrative costs	FY2026	$1.13B – $1.23B	New
May 7, 2026	research and development costs	FY2026	$800.00M – $900.00M	Lowered
May 7, 2026	total revenue	FY2026	$2.74B – $2.82B	New
Feb 26, 2026	gross margin 1	FY2026	63% – 65%	New
Feb 26, 2026	selling, general and administrative costs	FY2026	$1.13B – $1.23B	New
Feb 26, 2026	research and development costs	FY2026	$750.00M – $850.00M	Lowered
Feb 26, 2026	total revenue	FY2026	$2.62B – $2.70B	New
Nov 6, 2025	gross margin	FY2025	62% – 64%	Raised
Nov 6, 2025	selling, general and administrative costs	FY2025	$1.08B – $1.18B	Raised
Nov 6, 2025	research and development costs	FY2025	$575.00M – $625.00M	Lowered
Nov 6, 2025	net cash inflow	FY2025	$100.00M	Lowered
Nov 6, 2025	total revenue	FY2025	$2.18B – $2.26B	Raised
Aug 7, 2025	gross margin	FY2025	61% – 64%	New
Aug 7, 2025	selling, general and administrative costs	FY2025	$975.00M – $1.05B	New
Aug 7, 2025	research and development costs	FY2025	$550.00M – $590.00M	Lowered
Aug 7, 2025	total revenue	FY2025	$2.02B – $2.10B	New
May 8, 2025	gross margin	FY2025	60% – 64%	Reaffirmed
May 8, 2025	selling, general and administrative costs	FY2025	$975.00M – $1.05B	Raised
May 8, 2025	research and development costs	FY2025	$550.00M – $590.00M	Lowered
May 8, 2025	total revenue	FY2025	$1.94B – $2.02B	Raised
Feb 27, 2025	gross margin	FY2025	60% – 64%	New
Feb 27, 2025	selling, general and administrative costs	FY2025	$950.00M – $975.00M	New
Feb 27, 2025	research and development costs	FY2025	$525.00M – $550.00M	Lowered
Feb 27, 2025	total revenue	FY2025	$1.87B – $1.95B	New
Nov 12, 2024	gross margin	FY2024	58% – 61%	Raised
Nov 12, 2024	selling, general and administrative costs	FY2024	$775.00M – $825.00M	Raised
Nov 12, 2024	research and development costs	FY2024	$375.00M – $400.00M	Lowered
Nov 12, 2024	net cash inflow	FY2024	$50.00M – $75.00M	Lowered
Nov 12, 2024	total revenue	FY2024	$1.61B – $1.64B	Raised
Aug 8, 2024	gross margin	FY2024	54% – 56%	Raised
Aug 8, 2024	selling, general and administrative costs	FY2024	$700.00M – $750.00M	Raised
Aug 8, 2024	research and development costs	FY2024	$350.00M – $375.00M	Lowered
Aug 8, 2024	net cash (outflow) inflow	FY2024	-$25.00M – $25.00M	Lowered
Aug 8, 2024	total revenue	FY2024	$1.49B – $1.52B	Raised
May 9, 2024	gross margin	FY2024	53% – 55%	Raised
May 9, 2024	selling, general and administrative costs	FY2024	$700.00M – $750.00M	Raised
May 9, 2024	research and development costs	FY2024	$350.00M – $375.00M	Lowered
May 9, 2024	net cash inflow (consumption)	FY2024	-$25.00M – $25.00M	Lowered
May 9, 2024	total revenue	FY2024	$1.42B – $1.45B	Raised
Feb 28, 2024	gross margin	FY2024	50% – 53%	New
Feb 28, 2024	selling, general and administrative costs	FY2024	$630.00M – $650.00M	New
Feb 28, 2024	research and development costs	FY2024	$325.00M – $345.00M	Lowered
Feb 28, 2024	net cash consumption	FY2024	$50.00M – $75.00M	Lowered
Feb 28, 2024	total revenue	FY2024	$1.32B – $1.35B	New
Nov 8, 2023	GAAP net purchases of property and equipment	FY2023	$50.00M	Reaffirmed
Nov 8, 2023	gross margin	FY2023	43% – 44%	Raised
Nov 8, 2023	selling, general and administrative costs	FY2023	$540.00M – $580.00M	Raised
Nov 8, 2023	research and development costs	FY2023	$325.00M – $345.00M	Lowered
Nov 8, 2023	GAAP net cash used by operating activities	FY2023	$210.00M – $230.00M	Lowered
Nov 8, 2023	net cash consumption	FY2023	$260.00M – $280.00M	Lowered
Nov 8, 2023	annual revenue	FY2023	$1.04B – $1.05B	Raised
Aug 3, 2023	GAAP net purchases of property and equipment	FY2023	$50.00M	Reaffirmed
Aug 3, 2023	gross margin	FY2023	41% – 44%	Reaffirmed
Aug 3, 2023	selling, general and administrative costs	FY2023	$540.00M – $580.00M	Raised
Aug 3, 2023	research and development costs	FY2023	$325.00M – $345.00M	Lowered
Aug 3, 2023	net cash consumption	FY2023	$300.00M – $325.00M	Lowered
Aug 3, 2023	GAAP net cash used by operating activities	FY2023	$250.00M – $275.00M	Reaffirmed
Aug 3, 2023	total revenue	FY2023	$1.02B – $1.04B	New
May 9, 2023	GAAP net purchases of property and equipment	FY2023	$50.00M	Reaffirmed
May 9, 2023	gross margin	FY2023	41% – 44%	Reaffirmed
May 9, 2023	selling, general and administrative costs	FY2023	$510.00M – $540.00M	Raised
May 9, 2023	research and development costs	FY2023	$325.00M – $345.00M	Lowered
May 9, 2023	GAAP net cash used by operating activities	FY2023	$250.00M – $275.00M	Reaffirmed
May 9, 2023	net cash consumption	FY2023	$300.00M – $325.00M	New
Feb 28, 2023	GAAP net purchases of property and equipment	FY2023	$50.00M	New
Feb 28, 2023	gross margin	FY2023	41% – 44%	New
Feb 28, 2023	selling, general and administrative costs	FY2023	$510.00M – $540.00M	New
Feb 28, 2023	research and development costs	FY2023	$325.00M – $345.00M	Lowered
Feb 28, 2023	net cash consumption	FY2023	$300.00M – $325.00M	Lowered
Feb 28, 2023	GAAP net cash used by operating activities	FY2023	$250.00M – $275.00M	New
Nov 8, 2022	GAAP net purchases of property and equipment	FY2022	$60.00M	Reaffirmed
Nov 8, 2022	gross margin	FY2022	44% – 47%	Lowered
Nov 8, 2022	selling, general and administrative costs	FY2022	$575.00M – $590.00M	Raised
Nov 8, 2022	research and development costs	FY2022	$320.00M – $340.00M	Lowered
Nov 8, 2022	net cash consumption	FY2022	$450.00M	Raised
Nov 8, 2022	GAAP net cash used by operating activities	FY2022	$390.00M	Narrowed
Nov 8, 2022	total revenue	FY2022	$810.00M – $830.00M	Raised
Aug 4, 2022	GAAP net purchases of property and equipment	FY2022	$60.00M	Reaffirmed
Aug 4, 2022	gross margin	FY2022	46% – 48%	Reaffirmed
Aug 4, 2022	selling, general and administrative costs	FY2022	$560.00M – $590.00M	Raised
Aug 4, 2022	research and development costs	FY2022	$340.00M – $360.00M	Lowered
Aug 4, 2022	net cash consumption	FY2022	$370.00M – $400.00M	Raised
Aug 4, 2022	GAAP net cash used by operating activities	FY2022	$370.00M – $400.00M	Raised
Aug 4, 2022	total revenue	FY2022	$805.00M – $825.00M	Raised
May 5, 2022	GAAP net purchases of property and equipment	FY2022	$60.00M	Reaffirmed
May 5, 2022	gross margin	FY2022	46% – 48%	Reaffirmed
May 5, 2022	selling, general and administrative costs	FY2022	$560.00M – $590.00M	Raised
May 5, 2022	research and development costs	FY2022	$340.00M – $360.00M	Lowered
May 5, 2022	net cash consumption	FY2022	$370.00M – $400.00M	Raised
May 5, 2022	GAAP net cash used by operating activities	FY2022	$310.00M – $340.00M	Reaffirmed
May 5, 2022	total revenue	FY2022	$790.00M – $810.00M	Raised
Feb 24, 2022	GAAP net purchases of property and equipment	FY2022	$60.00M	New
Feb 24, 2022	gross margin	FY2022	46% – 48%	New
Feb 24, 2022	selling, general and administrative costs	FY2022	$560.00M – $590.00M	New
Feb 24, 2022	research and development costs	FY2022	$340.00M – $360.00M	Lowered
Feb 24, 2022	net cash consumption	FY2022	$370.00M – $400.00M	Raised
Feb 24, 2022	GAAP net cash used by operating activities	FY2022	$310.00M – $340.00M	New
Feb 24, 2022	total revenue	FY2022	$770.00M – $790.00M	New
Nov 4, 2021	GAAP net purchases of property and equipment	FY2021	$45.00M	New
Nov 4, 2021	gross margin	FY2021	49% – 52%	New
Nov 4, 2021	selling, general and administrative costs	FY2021	$500.00M – $520.00M	New
Nov 4, 2021	research and development costs	FY2021	$240.00M – $260.00M	Lowered
Nov 4, 2021	net cash consumption	FY2021	$300.00M – $340.00M	Raised
Nov 4, 2021	GAAP net cash used by operating activities	FY2021	$255.00M – $295.00M	New
Nov 4, 2021	total revenue	FY2021	$615.00M – $625.00M	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.